San Francisco, CA
Marea Therapeutics is a clinical-stage biotechnology firm that uses the most recent advancements in human genetics to create first-in-class, next-generation medications for cardiometabolic illnesses.
mareatx.comThese are collections Marea Therapeutics is a part of. Click on the collection name to view similar companies.
Series A
$65,418,629
Series B
$190,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Marea Therapeutics.